ArticleBone marrow transplantation2021

Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.

Yoshimitsu Shimomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.